A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11571347.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Levetiracetam was recently approved as adjunctive therapy for partial onset seizures. The authors conducted an open-label trial of levetiracetam in eight patients with chronic myoclonus. Patients were assessed by using the Unified Myoclonus Rating Scale. Levetiracetam was well tolerated. Three of five patients with cortical myoclonus experienced reductions in their myoclonus scores, providing support for a larger, placebo-controlled trial in cortical myoclonus.
Medical subject headings
- Anticonvulsants
- Epilepsies, Myoclonic
- Piracetam